Morphine Sulfate Injection · #6 of 35 active shortages by FDA posting duration
Brand: MORPHINE SULFATE
FDA lists Morphine Sulfate Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Unavailable
Morphine Sulfate Injection: Active Shortage
Unavailable 27 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Morphine Sulfate Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)
- Package NDC
- 63323-452-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Oct 31, 2017
- Last Updated
- Feb 25, 2026
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Next release not available at this time. Check wholesalers for inventory.
Full Drug Profile
morphine
Side effects, interactions, warnings & more
Nearby, Other Morphine Shortage Records
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Piramal Critical Care Inc.
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Fresenius Kabi USA, LLC
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
Morphine Sulfate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Next release not available at this time. General shortage guidance lives on the tracker hub.